Specification
Certificate of analysis
Scan the QR code on your vial, or type the batch number, and you get the analytical data for the exact vial you received.
Verify your vial →Cartalax
Ala-Glu-Asp-Gly (AEDG-related cartilage bioregulator)
A short peptide bioregulator from the Khavinson series, studied in cartilage and connective-tissue models.
What the literature describes
Cartalax belongs to the family of short peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology. The underlying research programme proposes that very short peptides interact with specific DNA sequences and histones to modulate gene expression in a tissue-selective manner. Published work in this series reports osteoprotective effects of cartilage-derived peptide preparations in ageing rats, and broader investigation of short peptides in telomere biology. Note that the evidence base for this compound class is smaller and more geographically concentrated than for the peptides above — much of it is published in Russian-language journals.
Available sizes & pricing
Price is per single sealed vial, in USD. Buying several — volume pricing.
| Vial strength | Price | |
|---|---|---|
| 20mg | $210 | Order 20mg |
Published research
Links open peer-reviewed sources on PubMed. These are provided so you can read the primary literature yourself. Citing a study is not a claim that this compound is safe or effective for any use in humans.
Research areas
Studied in the same area
TB-500 (Thymosin Beta-4)
Thymosin β-4 fragment (Ac-SDKP related)
The synthetic analogue of thymosin beta-4, the principal actin-sequestering peptide in eukaryotic cells and a long-studied regulator of tissue repair.
GHK-Cu (Copper Peptide)
Copper tripeptide-1, glycyl-L-histidyl-L-lysine:Cu(II)
A naturally occurring copper-binding tripeptide whose plasma concentration falls sharply with age; the best-characterised peptide in dermal remodelling literature.